Discontinued — last reported Q4 '20
Kimberly-Clark Business Sale Proceeds increased by 28.6% to $27.00M in Q1 2026 compared to the prior quarter. Over 4 years (FY 2021 to FY 2025), Business Sale Proceeds shows a downward trend with a -6.4% CAGR.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
proceeds_from_sale_of_business| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.75M | $10.75M | $10.75M | $3.00M | $3.00M | $3.00M | $3.00M | $61.25M | $61.25M | $61.25M | $61.25M | $162.75M | $162.75M | $162.75M | $162.75M | $0.00 | $12.00M | $0.00 | $21.00M | $27.00M |
| QoQ Change | — | +0.0% | +0.0% | -72.1% | +0.0% | +0.0% | +0.0% | >999% | +0.0% | +0.0% | +0.0% | +165.7% | +0.0% | +0.0% | +0.0% | -100.0% | — | -100.0% | — | +28.6% |
| YoY Change | — | — | — | — | -72.1% | -72.1% | -72.1% | >999% | >999% | >999% | >999% | +165.7% | +165.7% | +165.7% | +165.7% | -100.0% | -92.6% | -100.0% | -87.1% | — |